There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who ...

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced that, on March 28, 2025, it exercised its licensing option for the exclusive, worldwide rights to advance ...

Norgine and Theravia announced today that they have entered into a definitive agreement under which Norgine will acquire Theravia, ...

In a USC Keck School of Medicine press release, senior author Susanne Hempel, PhD, said, "The main message is, if your doctor puts you on Paxlovid, you don't have to worry about serious side effects.

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

In accordance with CMS quality measures, interventions like provider/patient education and better access to care help reduce ...

Using risk assessment and nurse education in the High ED/Admission Risk Therapy (HEART) protocol reduced ED visits by 18% ...

Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders characterized by the clonal ...

Mauricio Umansky has been open about the rare blood disease he suffered from as a child. Read on to learn more about it.

Treatment consisted of 4-6 cycles of dose-dense intensive chemotherapy incorporating hyperfractionated ...

Telangana: Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the ...

Aurobindo Pharma announced that its wholly owned step-down subsidiary, CuraTeQ Biologics s.r.o., has received permission from the European Commission (EC) to market Dyrupeg in the European Union.